# Huntsman CORP: overview

HUN · NYSE · CIK 1307954 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hun.md) · [Financials](/companies/hun/financials.md) · [Filings](/companies/hun/filings.md) · [Insiders](/companies/hun/insiders.md)

Latest reported revenue: [$1.42bn](/filings/0001437749-26-014346.md) for Q1 FY2026, three months to 2026-03-31, from the 10-Q filed May 1, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-014346).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,574](/filings/0001437749-25-024325.md) | [1,540](/filings/0001437749-25-033805.md) | [1,452 d](/filings/0001437749-26-004524.md) | [1,410](/filings/0001437749-26-014346.md) | [1,458](/filings/0001437749-25-024325.md) | [1,460](/filings/0001437749-25-033805.md) | [1,355 d](/filings/0001437749-26-004524.md) | [1,420](/filings/0001437749-26-014346.md) |
| Gross margin | % | [15.4%](/filings/0001437749-25-024325.md) | [15.2%](/filings/0001437749-25-033805.md) | [12.9% d](/filings/0001437749-26-004524.md) | [14.3%](/filings/0001437749-26-014346.md) | [12.5%](/filings/0001437749-25-024325.md) | [14.0%](/filings/0001437749-25-033805.md) | [12.1% d](/filings/0001437749-26-004524.md) | [12.9%](/filings/0001437749-26-014346.md) |
| Operating margin | % | [2.2%](/filings/0001437749-25-024325.md) | [2.7%](/filings/0001437749-25-033805.md) | [(4.3%) d](/filings/0001437749-26-004524.md) | [3.0%](/filings/0001437749-26-014346.md) | [(8.2%)](/filings/0001437749-25-024325.md) | [0.4%](/filings/0001437749-25-033805.md) | [(4.4%) d](/filings/0001437749-26-004524.md) | [(1.1%)](/filings/0001437749-26-014346.md) |
| Net margin | % | [1.4%](/filings/0001437749-25-024325.md) | [(2.1%)](/filings/0001437749-25-033805.md) | [(9.7%) d](/filings/0001437749-26-004524.md) | [(0.4%)](/filings/0001437749-26-014346.md) | [(10.8%)](/filings/0001437749-25-024325.md) | [(1.7%)](/filings/0001437749-25-033805.md) | [(7.1%) d](/filings/0001437749-26-004524.md) | [(3.7%)](/filings/0001437749-26-014346.md) |
| Diluted EPS | $ per share | [0.13](/filings/0001437749-25-024325.md) | [(0.19)](/filings/0001437749-25-033805.md) | not reported | [(0.03)](/filings/0001437749-26-014346.md) | [(0.92)](/filings/0001437749-25-024325.md) | [(0.14)](/filings/0001437749-25-033805.md) | not reported | [(0.31)](/filings/0001437749-26-014346.md) |
| Free cash flow | $m | [(4.0) d](/filings/0001437749-25-024325.md) | [88.0 d](/filings/0001437749-25-033805.md) | [102 d](/filings/0001437749-26-004524.md) | [(110)](/filings/0001437749-26-014346.md) | [54.0 d](/filings/0001437749-25-024325.md) | [153 d](/filings/0001437749-25-033805.md) | [19.0 d](/filings/0001437749-26-004524.md) | [(91.0)](/filings/0001437749-26-014346.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7,670](/filings/0001437749-24-005185.md) | [8,023](/filings/0001437749-25-004205.md) | [6,111](/filings/0001437749-26-004524.md) | [6,036](/filings/0001437749-26-004524.md) | [5,683](/filings/0001437749-26-004524.md) |
| Gross margin | % | [20.7%](/filings/0001437749-24-005185.md) | [19.3%](/filings/0001437749-25-004205.md) | [14.8%](/filings/0001437749-26-004524.md) | [14.3%](/filings/0001437749-26-004524.md) | [13.2%](/filings/0001437749-26-004524.md) |
| Operating margin | % | [9.5%](/filings/0001437749-24-005185.md) | [8.4%](/filings/0001437749-25-004205.md) | [1.4%](/filings/0001437749-26-004524.md) | [(0.4%)](/filings/0001437749-26-004524.md) | [(2.3%)](/filings/0001437749-26-004524.md) |
| Net margin | % | [13.6%](/filings/0001437749-24-005185.md) | [5.7%](/filings/0001437749-25-004205.md) | [1.7%](/filings/0001437749-26-004524.md) | [(3.1%)](/filings/0001437749-26-004524.md) | [(5.0%)](/filings/0001437749-26-004524.md) |
| Diluted EPS | $ per share | [4.72](/filings/0001437749-24-005185.md) | [2.27](/filings/0001437749-25-004205.md) | [0.57](/filings/0001437749-26-004524.md) | [(1.10)](/filings/0001437749-26-004524.md) | [(1.65)](/filings/0001437749-26-004524.md) |
| Free cash flow | $m | [626](/filings/0001437749-24-005185.md) | [642](/filings/0001437749-25-004205.md) | [(21.0)](/filings/0001437749-26-004524.md) | [79.0](/filings/0001437749-26-004524.md) | [116](/filings/0001437749-26-004524.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hun/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $193.7m | 18,243,856 |  | Added +5,593,887 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $97.3m | 9,166,098 |  | Reduced −645,078 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $92.5m | 8,713,741 |  | Reduced −2,876,925 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $80.7m | 7,594,395 |  | Added +3,341,528 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $79.8m | 7,514,930 |  | Reduced −28,239 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $60.7m | 5,716,848 |  | Reduced −267,145 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $58.8m | 5,535,356 |  | Reduced −1,415,421 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $58.8m | 5,534,163 |  | Added +1,960,509 |
| [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $54.8m | 5,161,672 |  | Reduced −654,687 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $54.6m | 5,142,372 |  | Added +1,470,501 |

## Recent filings

[All 1,600 filings](/companies/hun/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-25 | 16:45 ET | [8-K](/filings/0001104659-26-100848.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-100848 |
| 2026-08-18 | 18:00 ET | [8-K](/filings/0001104659-26-097961.md) | 8.01 Other events | 0001104659-26-097961 |
| 2026-07-31 | 11:20 ET | [10-Q](/filings/0001437749-26-025186.md) | Quarterly report, period 2026-06-30 | 0001437749-26-025186 |
| 2026-07-30 | 16:30 ET | [8-K](/filings/0001104659-26-088729.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-088729 |
| 2026-06-16 | 17:10 ET | [8-K](/filings/0001104659-26-074683.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074683 |
| 2026-06-16 | 06:26 ET | [8-K](/filings/0001104659-26-074266.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-074266 |
| 2026-05-01 | 16:15 ET | [8-K](/filings/0001104659-26-054144.md) | 5.07 Shareholder vote results | 0001104659-26-054144 |
| 2026-05-01 | 11:38 ET | [10-Q](/filings/0001437749-26-014346.md) | Quarterly report, period 2026-03-31 | 0001437749-26-014346 |
| 2026-04-30 | 16:30 ET | [8-K](/filings/0001104659-26-053018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-053018 |
| 2026-03-16 | 16:05 ET | [DEF 14A](/filings/0001104659-26-028448.md) | Proxy statement, period 2026-04-29 | 0001104659-26-028448 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-004524.md), filed Feb 18, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1307954
- Tickers: HUN
- Exchange: NYSE
- SIC code: 2800 Chemicals & Allied Products
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:57 ET. No prices; not investment advice.